Starovasnik Melissa A. 4

What Happened Melissa A. Starovasnik, a director of Twist Bioscience Corp (TWST), received an award of 5,095 shares on 2026-02-05. The shares were granted at $0.00 (code A — award/grant), so there was no cash purchase price; the reported value at grant is $0. This is an equity award typical for non-employee directors and is not a sale.

Key Details

• Transaction date: 2026-02-05; Form 4 filed 2026-02-09 (appears to be filed after the transaction date; Form 4s are generally due within two business days).
• Shares granted: 5,095; price reported: $0.00; total reported value at grant: $0.
• Vesting: 100% of the shares vest upon the earlier of (i) one-year anniversary of grant or (ii) the first annual meeting of stockholders following the grant date, provided the director remains a service provider (per footnote).
• Shares owned after the reported transaction: not specified in the provided filing details.
• Transaction code: A (award/grant).

Context This is a routine director equity award (restricted shares) tied to continued service rather than an open-market purchase or sale. Such awards are common for compensating non-employee directors and do not, by themselves, indicate a near-term sale or purchase intent. The vesting condition means the shares may remain restricted until the vesting date.